4//SEC Filing
Protalix BioTherapeutics, Inc. 4
Accession 0001178913-14-003121
$PLXCIK 0001006281operating
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 6:00 PM ET
Size
7.4 KB
Accession
0001178913-14-003121
Insider Transaction Report
Form 4
Bronfeld Zeev
Director10% Owner
Transactions
- Other
Common Stock
2014-10-02+324,372→ 2,162,481 total - Other
Common Stock
2014-10-02−1,509,948→ 0 total(indirect: By Trust)
Footnotes (4)
- [F1]Biocell Ltd. distributed 1,509,948 shares of common stock of Protalix BioTherapeutics, Inc., in a dividend to its shareholders on a pro rata basis based on their respective percentage interests in Biocell Ltd. Biocell Ltd. is an Israeli public company traded on the Tel Aviv Stock Exchange Ltd.
- [F2]The shares were transferred to the Biocell Ltd. shareholders on a pro rata basis based on their respective percentage interests in Biocell Ltd. No consideration was paid in connection with the transfer.
- [F3]The reporting person, a shareholder of Biocell Ltd., received shares of Protalix BioTherapeutics, Inc. common stock pursuant to the dividend made by Biocell Ltd. described in this Form 4. The shares received are limited to the reporting person's percentage interest in Biocell Ltd. The reporting person continues to hold such shares.
- [F4]No consideration was paid in connection with the transfer.
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001006281
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 6:00 PM ET
- Size
- 7.4 KB